Country (City) | No. examined | Prevalence (%) | Locus | Detection method | Time tested (year) | Reference |
---|---|---|---|---|---|---|
Australia (unknown) | 289 | 31.1 | SSU rRNA | PCR | 2005–2006 | [41] |
Canada (Edward) | 633 | 1.0 | SSU rRNA, bg | Immunofluorescence microscopy and PCR | 2007 | [48] |
Canada (Ontario) | 122 | 66.4 | SSU rRNA, bg | Immunofluorescence microscopy and PCR | 2005–2006 | [42] |
Canada (unknown) | 236 | 9.0 | –a | Immunofluorescence microscopy | 1995 | [54] |
Cambodia (Preah Vihear) | 76 | 0 | SSU rRNA | Immunofluorescence microscopy and PCR | 2012 | [49] |
China (Shaanxi) | 560 | 8 | bg, tpi, gdh | PCR | 2016–2017 | This study |
Denmark (unknown) | 1237 | 17.4 | –a | Immunofluorescence microscopy | 2003–2004 | [43] |
Denmark (unknown) | 856 | 14.0 | SSU rRNA, gdh | Immunofluorescence microscopy and PCR | 2011–2012 | [44] |
Denmark (unknown) | 1237 | 17.4 | SSU rRNA, gdh | PCR | 2003–2004 | [45] |
Turkey (Istanbul) | 238 | 3.7 | – a | Immunofluorescence microscopy | 2005 | [50] |
Norway (unknown) | 684 | 1.5 | SSU rRNA | Immunofluorescence microscopy and PCR | 2004–2005 | [51] |
Poland (unknown) | 84 | 9.5 | bg | Immunofluorescence microscopy and PCR | 2013–2014 | [46] |
UK (Preston, Cheshire) | 7 | 57.1 | SSU rRNA | PCR | 2007–2008 | [47] |
USA (Ohio) | 325 | 7.4 | –a | Immunofluorescence microscopy | 1993 | [52] |
Zambia (Lusaka) | 217 | 12.0 | –a | Immunofluorescence microscopy | 2011 | [25] |